Tarceva and haemoptysis Patient Reports March 18, 2010
Tarceva Side Effects Report #5255228-8
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Feb 12, 2007. Female patient was diagnosed with sarcoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, platelet count decreased. Tarceva dosage: unknown. Patient recovered.
Tarceva Side Effects Report #4910613-6
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Feb 10, 2006. Female patient, 53 years of age, weighting 143.3 lb, was diagnosed with renal cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: catheter related complication, cellulitis
, folliculitis, haemoptysis, heart rate increased, malnutrition, nausea
, rash
, rash macular. Tarceva dosage: 150 MG PO QD. During the same period patient was treated with AVASTIN, GLUCOTROL, RED BLOOD CELLS, MAGNESIUM OXIDE, KEFLEX, VANCOMYCIN, PROTONIX. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #5748800-X
Tarceva side effect was reported by a Physician from IRELAND on May 06, 2008. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, haemoglobin decreased, haemoptysis, infection
, nausea
, platelet count increased, rash
. Tarceva dosage: 150 MG, ORAL, 100 MG, QD, ORAL. During the same period patient was treated with ASPIRIN, PREDNISOLONE, CARDURA, RAMIPRIL, ISOSORBIDE MONONITRATE, LIPITOR, FUROSEMIDE. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #4653296-5
Tarceva side effect was reported by a Pharmacist from on May 03, 2005. Male patient, 57 years of age, weighting 211.2 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoptysis, thrombocytopenia. Tarceva dosage: 150 MG PO Q DAY. During the same period patient was treated with VALSARTAN, PRAVASTATIN, EZETIMIBE, ACYCLOVIR, FOLIC ACID, LORATADINE, HYDROCODONE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5744722-9
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 15, 2008. Female patient, 82 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: erythema, haemoptysis, hypoacusis, hypotrichosis, insomnia, international normalised ratio increased, rhinorrhoea, visual acuity reduced, weight decreased. Tarceva dosage: (25 MG, QD), ORAL. During the same period patient was treated with POTASSIUM, FUROSEMIDE, AMIODARONE, WARFARIN, DIGOXIN, SYNTHROID. Patient recovered.
Tarceva Side Effects Report #5586970-7
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Dec 21, 2007. Male patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: coma, cough, dyspnoea, haemoptysis, hypoaesthesia oral, mouth ulceration, odynophagia, rash papular, rash pruritic. Tarceva dosage: 150 MG, QD, ORAL. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5631934-8
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Jan 28, 2008. Male patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: coma, cough, dyspnoea, haemoptysis, hypoaesthesia, mouth ulceration, odynophagia, oral pain, pruritus. Tarceva dosage: 150 MG, QD, ORAL. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5394873-6
Tarceva side effect was reported by a Physician from CHINA on July 05, 2007. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #4718031-0
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2005. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, exfoliative rash, haemoptysis, rash erythematous, skin fissures, urine odour abnormal. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #4718240-0
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 21, 2005. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: arthralgia, cough, dysphonia, flatulence, gastrooesophageal reflux disease, haemoptysis, headache
, increased upper airway secretion, nail disorder. Tarceva dosage: 150 MG (QD), ORAL; 150 MG (QOD), ORAL. During the same period patient was treated with NEXIUM. Patient recovered.Tarceva Side Effects Report #5394875-X
Tarceva side effect was reported by a Physician from CHINA on July 05, 2007. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5409382-5
Tarceva side effect was reported by a Physician from CHINA on July 30, 2007. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, haemoptysis, respiratory failure. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 06/28/2007.
Tarceva Side Effects Report #5935293-2
Tarceva side effect was reported by a Physician from ITALY on Oct 14, 2008. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cough, dyspnoea, haemoptysis, lung infiltration, respiratory failure. Tarceva dosage: (150 MG, QD), ORAL. During the same period patient was treated with AMIODARONE, GABAPENTIN, JURNISTA. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #6060237-5
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Jan 16, 2009. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, hepatic neoplasm, malignant neoplasm progression, pyrexia. Tarceva dosage: 150 MG, QD, ORAL. During the same period patient was treated with THYMOPENTIN, XIHUANG WAN, YUNNAN BAIYAO. Patient recovered.
Tarceva Side Effects Report #4718014-0
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2005. Female patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, rash vesicular. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with ASPIRIN. Patient recovered.
Tarceva Side Effects Report #4899887-8
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: dyspnoea exacerbated, haemoptysis. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with LIPITOR, ZANTAC, CALCIUM GLUCONATE, ZOLOFT, WARFARIN. Patient recovered.
Tarceva Side Effects Report #5385595-6
Tarceva side effect was reported by a Physician from CHINA on June 25, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cough, cyanosis, dyspnoea, haemoptysis, pyrexia, respiratory failure, white blood cell count increased. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5422998-5
Tarceva side effect was reported by a Physician from CHINA on Aug 03, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cough, disease progression, haemoptysis, pyrexia, respiratory failure, white blood cell count increased. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.
Tarceva Side Effects Report #6023263-8
Tarceva side effect was reported by a Health Professional from ITALY on Dec 09, 2008. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: (150 MG,QD),ORAL. Patient recovered.
Tarceva Side Effects Report #5074885-2
Tarceva side effect was reported by a Health Professional from UNITED STATES on Nov 07, 2005. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with COUMADIN. Patient recovered.
Tarceva Side Effects Report #4899818-0
Tarceva side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2005. Male patient, 70 years of age, weighting 136.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, dyspnoea, fatigue, haemoptysis, rash
. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.Tarceva Side Effects Report #5509041-4
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Oct 19, 2007. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, haemoptysis, mouth ulceration, pharyngeal oedema, pharyngolaryngeal pain, pyrexia, rash
. Tarceva dosage: 150MG, ORAL. Patient recovered.Tarceva Side Effects Report #5069183-7
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2005. Female patient, 67 years of age, weighting 100.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, cough, dry skin, dyspnoea, faeces discoloured, fatigue, haemoptysis, hypersensitivity. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #4899549-7
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2005. Female patient, 67 years of age, weighting 100.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, cough, dry skin, dyspnoea, faeces discoloured, fatigue, haemoptysis. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #4561183-6
Tarceva side effect was reported by a Physician from on Jan 04, 2005. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cerebral infarction, cerebrovascular accident, disseminated intravascular coagulation, haemoptysis, platelet count decreased, pneumonitis, pulmonary embolism
, transient ischaemic attack. Tarceva dosage: 150 MG (TWICE A WK), ORAL. During the same period patient was treated with WARFARIN, PAROXETINE HYDROCHLORIDE, ZOLPIDEM TARTRATE, DOCUSATE, OXYOCOCET. Patient was hospitalized. Patient died on 01/10/2005.Tarceva Side Effects Report #4728274-8
Tarceva side effect was reported by a Physician from UNITED STATES on July 12, 2005. Male patient, 64 years of age, weighting 170.0 lb, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, haemoptysis, thrombotic thrombocytopenic purpura. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with VELCADE, DECADRON, METOPROLOL TARTRATE, ZESTORETIC. Patient was hospitalized. Patient died on 07/04/2005.
Tarceva Side Effects Report #5445963-0
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Aug 17, 2007. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cough, diarrhoea, haemoptysis, rash
. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #5875471-4
Tarceva side effect was reported by a Physician from UNITED KINGDOM on Aug 20, 2008. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, hypoxia, ill-defined disorder, malaise. Tarceva dosage: (150 MG, QD) ,ORAL. Patient died.
Tarceva Side Effects Report #4749879-4
Tarceva side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis, heparin-induced thrombocytopenia, malignant neoplasm progression, prothrombin time prolonged, pulmonary embolism
. Tarceva dosage: 150 MG (QD (HELD 7/22/2005)), ORAL. During the same period patient was treated with ATENOLOL, HYDROCHLOROTHIAZIDE, SINEMET, AMANTADINE, ACETYLSALICYLIC ACID SRT, ZOCOR, ALBUTEROL, CIMETIDINE. Patient was hospitalized. Patient died on 08/04/2005.Tarceva Side Effects Report #5913805-2
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Sept 23, 2008. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: abdominal pain
, body temperature increased, haemoptysis, pruritus, skin exfoliation, thrombosis. Tarceva dosage: (150 MG), ORAL. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #5932686-4
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Oct 09, 2008. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: abdominal pain
, anorexia, body temperature increased, dyspepsia, epistaxis, flatulence, haemoptysis, pruritus, skin exfoliation. Tarceva dosage: (150 MG, QD0, ORAL, (75 MG, QD), ORAL, (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #5705280-8
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Mar 27, 2008. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: condition aggravated, diarrhoea, haemoptysis. Tarceva dosage: 150 MG, QD. During the same period patient was treated with ZOMETA. Patient recovered.
Tarceva Side Effects Report #5963770-7
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Nov 05, 2008. Male patient, 58 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: bone pain, condition aggravated, haemoptysis. Tarceva dosage: 150 MG QD ORAL. Patient recovered.
Tarceva Side Effects Report #5740035-X
Tarceva side effect was reported by a Physician from on Mar 07, 2008. Female patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: (150 MG,QD),ORAL. Patient died.
Tarceva Side Effects Report #4718113-3
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Apr 14, 2005. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: faeces discoloured, haemoptysis, melaena, thrombocytopenia. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5891568-7
Tarceva side effect was reported by a Physician from BELGIUM on Sept 03, 2008. Female patient, 54 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: bronchial haemorrhage, haemoglobin decreased, haemoptysis, hepatic infarction, hepatotoxicity, inflammation, malignant neoplasm progression, metastases to liver. Tarceva dosage: (150 MG,QD), ORAL. During the same period patient was treated with AUGMENTIN, ACETAMINOPHEN, ENOXAPARIN, MEDROL, PANTOPRAZOLE, FLUOXETINE, PARASOL, CLONAZEPAM. Patient was hospitalized. Patient died.
Tarceva Side Effects Report #4815996-3
Tarceva side effect was reported by a Health Professional from UNITED STATES on Oct 12, 2005. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: acute respiratory failure, epistaxis, haemolytic uraemic syndrome, haemoptysis, lung infiltration, pulmonary alveolar haemorrhage, pulmonary mass, respiratory distress, staphylococcal infection
. Tarceva dosage: 125 MG (QD), ORAL. During the same period patient was treated with VERAPAMIL, METOPROLOL TARTRATE, CLONIDINE, FOLIC ACID, PREVACID. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #6051227-7
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Jan 05, 2009. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, haemoptysis. Tarceva dosage: (150 MG, QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5694304-2
Tarceva side effect was reported by a Physician from CHINA on Mar 26, 2008. Male patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: condition aggravated, haemoptysis, rash
. Tarceva dosage: (150 MG,QD),ORAL; (100 MG,QD),ORAL. Patient recovered.Tarceva Side Effects Report #5737890-6
Tarceva side effect was reported by a Physician from CHINA on Apr 25, 2008. Male patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, incorrect dose administered, metastases to central nervous system, metastases to liver, rash
. Tarceva dosage: (150 MG,QD),ORAL, (100 MG,QD),0RAL. Patient recovered.Tarceva Side Effects Report #4930306-9
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2005. Female patient, 44 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cough, haemoptysis. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #4899560-6
Tarceva side effect was reported by a Pharmacist from UNITED STATES on June 21, 2005. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with LOW MOLECULAR WEIGHT HEPARIN. Patient recovered.
Tarceva Side Effects Report #6073100-0
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Jan 21, 2009. Female patient, child 10 years of age, was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: condition aggravated, haemoptysis. Tarceva dosage: (150 MG,QD),ORAL. Patient recovered.
Tarceva Side Effects Report #5241231-0
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Feb 12, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: unknown. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5385176-4
Tarceva side effect was reported by a Physician from UNITED KINGDOM on June 22, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: accident, haemoptysis, malaise. Tarceva dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5385177-6
Tarceva side effect was reported by a Physician from UNITED KINGDOM on June 22, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: accident, haemoptysis, malaise. Tarceva dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5803940-1
Tarceva side effect was reported by a Physician from BELGIUM on June 20, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: bronchial haemorrhage, haematemesis, haemoptysis, hepatitis
, inflammation. Tarceva dosage: (150 MG, QD), ORAL. During the same period patient was treated with AUGMENTIN, ACETAMINOPHEN, ENOXAPARIN. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #5872408-9
Tarceva side effect was reported by a Physician from UNITED KINGDOM on Aug 18, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haematuria, haemoptysis, metastasis, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Tarceva dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with AZATHIOPRINE, VALPROATE, ITRACONAZOLE, PYRIDOSTIGMINE. Patient died.
Tarceva Side Effects Report #5875394-0
Tarceva side effect was reported by a Physician from BELGIUM on Aug 22, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: bronchial haemorrhage, bronchitis chronic, c-reactive protein increased, dyspnoea, haemoglobin decreased, haemoptysis, hepatitis
, infection
. Tarceva dosage: 150 MG, QD, ORAL. During the same period patient was treated with AUGMENTIN, ACETAMINOPHEN, ENOXAPARIN. Patient was hospitalized. Patient died.Tarceva Side Effects Report #6049962-X
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Jan 05, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: anaemia, cough, dyspnoea, haemoptysis. Tarceva dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #4735203-X
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2005. Male patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, haematemesis, haemoptysis, hypotension, oesophageal ulcer, pharyngeal ulceration, rash pruritic. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with OMEPRAZOLE, SINGULAIR. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #4899910-0
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2005. Male patient was diagnosed with non-small cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: face oedema, haemoptysis, rash
. Tarceva dosage: unknown. Patient recovered.Tarceva Side Effects Report #5068162-3
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2006. Female patient, 53 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, rash
. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with AVASTIN, GLUCOTROL, PACKED RED BLOOD CELLS, MAGNESIUM OXIDE, KEFLEX, VANCOMYCIN, PROTONIX. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #6010185-1
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Dec 01, 2008. Male patient, 78 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: 150 MG, QD, ORAL. Patient recovered.
Tarceva Side Effects Report #5512590-6
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Oct 22, 2007. Male patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: fatigue, haemoptysis, urinary incontinence
. Tarceva dosage: 150 MG, QD, ORAL. Patient died on 10/07/2007.Tarceva Side Effects Report #5042539-4
Tarceva side effect was reported by a Pharmacist from FRANCE on June 09, 2006. Male patient, 65 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, pulmonary haemorrhage. Tarceva dosage: unknown. Patient died.
Tarceva Side Effects Report #5147101-0
Tarceva side effect was reported by a Pharmacist from FRANCE on Oct 18, 2006. Male patient, 64 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, interstitial lung disease, pulmonary haemorrhage. Tarceva dosage: unknown. Patient was hospitalized. Patient died.
Tarceva Side Effects Report #5420774-0
Tarceva side effect was reported by a Physician from GERMANY on Aug 01, 2007. Female patient, 63 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: anaemia of malignant disease, blood thyroid stimulating hormone increased, breast mass, breast neoplasm, cellulitis
, haemoptysis, hypokalaemia, hyponatraemia, metastases to lung. Tarceva dosage: 150 MG (QD),ORAL. During the same period patient was treated with PREDNISOLONE, HYDROCHLOROTHIAZIDE, PANTOZOL, LEVOTHYROXINE, MOVICOL, IBUPROFEN, TOREM, MORPHINE. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #5670188-3
Tarceva side effect was reported by a Physician from NETHERLANDS on Feb 27, 2008. Female patient, 62 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: alopecia, bronchial obstruction, cerebellar haemorrhage, cerebral haemorrhage, cerebral ischaemia, haemoptysis, malignant neoplasm progression, metastases to central nervous system, non-small cell lung cancer metastatic. Tarceva dosage: 150 MG, QD, ORAL. During the same period patient was treated with PREDNISONE, TEMAZEPAM. Patient was hospitalized. Patient died on 01/17/2008.
Tarceva Side Effects Report #6100519-1
Tarceva side effect was reported by a Health Professional from UNITED STATES on Feb 11, 2009. Male patient, 58 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5679710-4
Tarceva side effect was reported by a Physician from on Mar 07, 2008. Female patient, 57 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: unknown. Patient died.
Tarceva Side Effects Report #5608397-1
Tarceva side effect was reported by a Consumer or non-health professional from SPAIN on Jan 11, 2008. Male patient, 56 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: (150 MG, QD),ORAL. Patient died.
Tarceva Side Effects Report #5465311-X
Tarceva side effect was reported by a Health Professional from UNITED STATES on Sept 19, 2007. Female patient, 43 years of age, weighting 154.6 lb, was diagnosed with lung neoplasm malignant, metastases to central nervous system and was treated with Tarceva. After drug was administered, patient experienced the following side effects: cellulitis
, chills, diarrhoea, haemoptysis, headache
, hyperhidrosis, hypoxia, lung adenocarcinoma, metastases to central nervous system. Tarceva dosage: 150MG PO DAILY. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #5301584-1
Tarceva side effect was reported by a Physician from BRAZIL on Mar 27, 2007. Male patient, 42 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: acne
, depression
, erythema, haemoptysis, poisoning
, rash
. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.Tarceva Side Effects Report #5413294-0
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on July 27, 2007. Male patient, 41 years of age, was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: dyspnoea, haemoptysis, respiratory failure. Tarceva dosage: 150 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5431641-0
Tarceva side effect was reported by a Pharmacist from UNITED STATES on Aug 13, 2007. Male patient was diagnosed with lung neoplasm malignant and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5631799-4
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Jan 30, 2008. Male patient, 61 years of age, was diagnosed with lung cancer metastatic and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis. Tarceva dosage: (150 MG, QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5797857-9
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on June 24, 2008. Male patient, 46 years of age, was diagnosed with lung adenocarcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: disease progression, gastric haemorrhage, haemoptysis, occult blood positive, oedema, onychoclasis, pruritus, rash pustular. Tarceva dosage: (150 MG,QD), ORAL. Patient died.
Tarceva Side Effects Report #5631937-3
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Jan 29, 2008. Male patient, 40 years of age, was diagnosed with lung adenocarcinoma and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, dry skin, erythema, haemoptysis, rash
, skin exfoliation. Tarceva dosage: 150 MG, QD, ORAL. Patient recovered.Tarceva Side Effects Report #5075027-X
Tarceva side effect was reported by a Health Professional from UNITED STATES on Jan 25, 2006. Female patient, 83 years of age, was diagnosed with adenosquamous cell lung cancer and was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, haemoptysis. Tarceva dosage: 100 MG (QD), ORAL. During the same period patient was treated with LASIX, ALBUTEROL, ASPIRIN, WARFARIN, LAMISIL, ALTACE, TRAMADOL, SYNTHROID. Patient recovered.
Tarceva Side Effects Report #4740927-4
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on July 21, 2005. Male patient, 87 years of age, was diagnosed with metastases to lung and was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, obstruction. Tarceva dosage: 150 MG (QD), ORAL. During the same period patient was treated with AVASTIN, NORVASC, FLOMAX, MARINOL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #4930433-6
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2005. Male patient, 57 years of age, was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, rash
. Tarceva dosage: 150MG (QD), ORAL. During the same period patient was treated with WARFARIN. Patient recovered.Tarceva Side Effects Report #5250759-9
Tarceva side effect was reported by a Consumer or non-health professional from CHINA on Feb 07, 2007. Male patient, 52 years of age, was treated with Tarceva. After drug was administered, patient experienced the following side effects: diarrhoea, haemoptysis, rash
, vomiting. Tarceva dosage: 150 MG, ORAL. Patient recovered.Tarceva Side Effects Report #5536592-9
Tarceva side effect was reported by a Pharmacist from on Nov 19, 2007. Male patient was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, skin reaction. Tarceva dosage: unknown. During the same period patient was treated with PLAVIX, LYRICA, METAMIZOL, FORTUM, NEXIUM, FUROSEMIDE, VERGENTAN. Patient recovered.
Tarceva Side Effects Report #4654153-0
Tarceva side effect was reported by a Health Professional from on Apr 18, 2005. Male patient was treated with Tarceva. After drug was administered, patient experienced the following side effects: haemoptysis, rash
. Tarceva dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.Tarceva Side Effects Report #4718056-5
Tarceva side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2005. Male patient was treated with Tarceva. After drug was administered, patient experienced the following side effects: acne
, condition aggravated, haemoptysis, rash
. Tarceva dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva and haemoptysis 